These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 28559270)

  • 1. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
    Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
    J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.
    Jayne JG; Bensman TJ; Schaal JB; Park AYJ; Kimura E; Tran D; Selsted ME; Beringer PM
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):310-319. PubMed ID: 28954201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
    Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
    Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
    Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
    Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.
    Milla CE; Chmiel JF; Accurso FJ; VanDevanter DR; Konstan MW; Yarranton G; Geller DE;
    Pediatr Pulmonol; 2014 Jul; 49(7):650-8. PubMed ID: 24019259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Inflammatory Effects of RTD-1 in a Murine Model of Chronic
    Dughbaj MA; Jayne JG; Park AYJ; Bensman TJ; Algorri M; Ouellette AJ; Selsted ME; Beringer PM
    Antibiotics (Basel); 2021 Aug; 10(9):. PubMed ID: 34572625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
    Wang Y; Cela E; Gagnon S; Sweezey NB
    Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.
    Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Rizzo R; Bergamini G; Bortolotti D; Leal T; D'Orazio C; Pintani E; Melchiorri L; Zavatti E; Assael BM; Sorio C; Melotti P
    Future Microbiol; 2016; 11(3):363-73. PubMed ID: 26934639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles secreted by primary human bronchial epithelial cells reduce
    Sarkar S; Barnaby R; Nymon AB; Taatjes DJ; Kelley TJ; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L164-L174. PubMed ID: 38084406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.